The frequency of PI3K mutations varies according to the BC subtype: In the Caucasian population, PI3K mutations are present in 34.5% of hormone receptor–positive patients, 22.7% of HER-2-positive patients, and 8.3% of basal–like BC patients harboring PI3K mutations [31]. Here, NR4A1 is linked to breast cancer.